Skip to the page

Data / Drug companies / Haleos Labs Limited

Haleos Labs Limited: 16 products in the FDA NDC directory, labeler code 72375

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Haleos Labs Limited (labeler code 72375) lists 16 products in the FDA National Drug Code Directory. By type: 16 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 30, 2026.

The request: Watch Haleos Labs Limited (FDA labeler code 72375): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72375
Products in commercial distribution
16
Packages
18
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
3
Earliest marketing start
June 28, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients16100%

Products by type

TypeProductsShare
Bulk ingredients16100%

Dosage forms

Dosage formProductsShare
Powder16100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dorzolamide hydrochloride72375-0017PowderBulk ingredientsMay 30, 2026
Cimetidine72375-0016PowderBulk ingredientsDecember 18, 2025
Timolol maleate72375-0015PowderBulk ingredientsNovember 7, 2025
Naphazoline hydrochloride72375-0014PowderBulk ingredientsDecember 13, 2024
Domperidone ph.eur.72375-0013PowderBulk ingredientsNovember 25, 2024
Sacubitril sodium72375-0012PowderBulk ingredientsNovember 5, 2024
Furosemide72375-0011PowderBulk ingredientsApril 8, 2024
Cimetidine72375-0010PowderBulk ingredientsApril 8, 2024
Minoxidil72375-0009PowderBulk ingredientsFebruary 23, 2024
Famotidine72375-0008PowderBulk ingredientsNovember 21, 2023
Allopurinol72375-0007PowderBulk ingredientsSeptember 3, 2022
Dapsone72375-0006PowderBulk ingredientsSeptember 3, 2021
Ropivacaine hydrochloride monohydrate72375-0004PowderBulk ingredientsDecember 2, 2020
Famotidine72375-0003PowderBulk ingredientsJuly 8, 2019
Ranitidine hydrochloride72375-0002PowderBulk ingredientsJuly 7, 2018
Sildenafil citrate72375-0001PowderBulk ingredientsJune 28, 2018

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.